Small Molecule API Market Size, Outlook, Overview 2024-2033

The Small Molecule API Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Small Molecule API Market:
https://www.thebusinessresearchcompany.com/report/small-molecule-api-global-market-report

According to The Business Research Company’s Small Molecule API Global Market Report 2024, The small molecule api market size has grown strongly in recent years. It will grow from $193.44  billion in 2023 to $206.88  billion in 2024 at a compound annual growth rate (CAGR) of 6.9%.  The  growth in the historic period can be attributed to rise of generic drug manufacturing, increased r&d investment, aging population demands, expansion in oncology treatments, emergence of targeted therapies..

The small molecule api market size is expected to see strong growth in the next few years. It will grow to $275.14  billion in 2028 at a compound annual growth rate (CAGR) of 7.4%.  The growth in the forecast period can be attributed to supply chain resilience, digitalization in pharmaceutical manufacturing, increasing investment in oncology, adoption of green chemistry, pandemic-driven healthcare needs.. Major trends in the forecast period include biopharmaceutical synergy, personalized medicine, advanced manufacturing techniques, api outsourcing and contract manufacturing..

The growing demand for small-molecule drugs is expected to propel the growth of the small-molecule API market. Small-molecule drugs refer to low-molecular-weight compounds that can modulate biochemical processes to diagnose, treat, or prevent disease. Aspirin, diphenhydramine, and other molecules commonly found in medicine cabinets are examples of small-molecule drugs. These molecule drug products come under the category of small molecule API products, which help in preventing disease. According to the National Center for Biotechnology Information (NCBI), in 2021, 75% of the drugs accepted by the Food and Drug Administration (FDA) were small molecules, with the dominant therapeutic area being oncology. Over 50% of these approvals were from small and mid-sized companies, which require support from CDMOs for the commercialization of products that contribute to the growth of CDMOs. Therefore, the growing demand for small-molecule drugs is driving the growth of the small-molecule API market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=8236&type=smp

The small molecule api market covered in this report is segmented –

1) By Type: Synthetic, Biotech

2) By Manufacturer: In-House, Outsourced

3) By Application: Cardiology, Oncology, CNS And Neurology, Orthopaedic, Endocrinology, Other Applications

Top Major Players:
Merck & Co. Inc.
AbbVie Inc.
Bristol-Myers Squibb Company
Albemarle Corporation
Boehringer Ingelheim International GmbH

North America was the largest region in the small molecule API market in 2023.

Strategic partnership is a key trend in the small-molecule API market. Many companies operating in the small-molecule API market are undergoing partnerships to strengthen their position in the small-molecule API market and advance the development of various drugs and therapies. For instance, in March 2023, CatSci Ltd, a UK-based pharmaceutical company partnered with AGC Pharma Chemicals, a Spain-based pharmaceutical company to fortify drug development. CatSci’s non-clinical specialization now leverages AGC’s manufacturing prowess, supporting clinical phase projects. AGC’s clients access CatSci’s advanced capabilities in therapeutic development, with a focus on scalable small molecule API manufacturing and diverse technologies. The collaboration prioritizes seamless tech transfer, aiming to provide strategic value, expedite drug development timelines, and deliver impactful small molecule API-based medicines globally.

The small molecule api market report table of contents includes:

1. Executive Summary
2. Small Molecule API Market Characteristics
3. Small Molecule API Market Trends And Strategies
4. Small Molecule API Market – Macro Economic Scenario
5. Global Small Molecule API Market Size and Growth
….…..
31. Global Small Molecule API Market Competitive Benchmarking
32. Global Small Molecule API Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Small Molecule API Market
34.Small Molecule API Market Future Outlook and Potential Analysis
35. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model